Neurovirulence tests of three 17D yellow fever vaccine strains

Biologicals

Volumn 39, Issue 3, 2011, Pages 167-170

  Minor, Philip D ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Neurovirulence; Seeds; Yellow fever vaccine

Indexed keywords

NEUTRALIZING ANTIBODY; YELLOW FEVER VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENCEPHALITIS; MACACA FASCICULARIS; NONHUMAN; PRIORITY JOURNAL; VIREMIA; VIRUS STRAIN; VIRUS VIRULENCE; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BRAIN; MACACA FASCICULARIS; MICE; SPINAL CORD; VIRULENCE; VIRUS CULTIVATION; YELLOW FEVER; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS;

EID: 79957501392     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2011.04.001     Document Type: Article

References (9)

1. Fox J.P., Penna H.A. Behaviour of 17D yellow fever virus in rhesus monkeys. Relation to substrain, dose and neural or extraneural inoculation. American Journal of Hygiene 1943, 38:152-172.
2. Recommendations to Assure the Quality, Safety and Efficacy of Live Attenuated Yellow Fever Vaccines Proposed replacement of: TRS 872, Annex 2 and Amendment to TRS 872, Annex 2, TRS (ECBS 2008); ECBS paper WHO/BS/10.2131, Geneva World Health Organization, in press.
3. Lindsey N.P., Schroeder B.A., Miller E.R., Braun M., Hinckley A.F., Marano N., et al. Adverse event reports following yellow fever vaccination. Vaccine 2008, 26:6077-6082.
4. Barrett A.D., Teuwen D.E. Yellow fever vaccine-how does it work and why do rare cases of serious adverse events take place?. Current Opinion in Immunology 2009, 21:308-313.
5. Levenbook I.S., Pelleu L.J., Elisberg B.L. The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination. Journal of Biological Standardization 1987, 15:305-313.
6. WHO expert committee on biological standardization. Thirty sixth report. WHO Technical Report Series No 745 1987, vol. 6. Production and testing of the WHO yellow fever virus primary seed lot 213-77 and reference batch 168-73, Annex, World Health Organization, Geneva.
7. World health organization expert committee on biological standardization twenty seventh report. WHO Technical Report Series No. 594 1976, vol. 1. Requirements for yellow fever vaccine (Requirements for Biological Substances No.3 revised 1975), Annex, World Health Organization, Geneva.
8. WHO expert committee on biological standardization. Thirty third report. WHO Technical Report Series 687 1983, vol. 4. Requirements for poliomyelitis vaccine (oral) (Revised 1982), Annex, World Health Organization, Geneva.
9. Post P.R., Santos C.N., Carvallho R., Cruz A.R., Ricet C.M., Galler R., et al. Heterogeneity in envelope protein sequence and N-linked glycosylation among yellow fever virus vaccine strains. Virology 1992, 188:160-167.